MedTrace Logo

Safety and Efficacy Study of the Cardiapex Percutaneous Trans-apical Access and Closure System

NCT01722591 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2015-02-04

No results posted yet for this study

Summary

A prospective, multicenter, uncontrolled study to evaluate the safety and efficacy of the Cardiapex percutaneous trans-apical access and closure system. The Cardiapex device intended for percutaneous access and closure of the left ventricular apex in conjunction with transapical Transcatheter Aortic Valve Implantation (TAVI).

Conditions

  • Transapical Transcatheter Aortic Valve Implantation

Interventions

DEVICE

Cardiapex device

Cardiapex percutaneous transapical access and closure system

Sponsors & Collaborators

  • Cardiapex Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01722591 on ClinicalTrials.gov